Yangyang Qi

1.3k total citations
21 papers, 779 citations indexed

About

Yangyang Qi is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, Yangyang Qi has authored 21 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Yangyang Qi's work include Cancer Immunotherapy and Biomarkers (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Yangyang Qi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Yangyang Qi collaborates with scholars based in China, Malaysia and Pakistan. Yangyang Qi's co-authors include Jiejie Xu, Weijuan Zhang, Yifan Chen, Qi Jiang, Lingli Chen, Chao Lin, Hongyong He, Ruochen Li, Yihong Sun and Hao Liu and has published in prestigious journals such as Cancer Research, Gut and British Journal of Cancer.

In The Last Decade

Yangyang Qi

20 papers receiving 776 citations

Peers

Yangyang Qi

IMMUN

ONCOL

PRM

Mengting Liao China

Qingyang Feng China

Qi Bai China

Yuling Chen Taiwan

Jhajaira M. Araujo Peru

Yongsheng Yang China

Xinna Zhou China

Guilin Peng China

Ali H. Zaidi United States

Mengting Liao China

Yangyang Qi

328 ×0.9

IMMUN

453 ×1.3

ONCOL

242 ×1.0

195 ×1.0

PRM

112 ×0.7

Citations per year, relative to Yangyang Qi Yangyang Qi (= 1×) peers Mengting Liao

Countries citing papers authored by Yangyang Qi

Since Specialization

Citations

This map shows the geographic impact of Yangyang Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyang Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyang Qi more than expected).

Fields of papers citing papers by Yangyang Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangyang Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyang Qi. The network helps show where Yangyang Qi may publish in the future.

Co-authorship network of co-authors of Yangyang Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Yangyang Qi. A scholar is included among the top collaborators of Yangyang Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangyang Qi. Yangyang Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qi, Yangyang, Jinxia Wang, Yani Chen, et al.. (2024). Safety, Immunogenicity, and Effectiveness of Chinese-Made COVID-19 Vaccines in the Real World: An Interim Report of a Living Systematic Review. Vaccines. 12(7). 781–781. 1 indexed citations

Zhang, Xue, et al.. (2023). Associations between R.E.N.A.L. nephrometry score and survival outcomes in renal tumours. Japanese Journal of Clinical Oncology. 54(3). 339–345. 1 indexed citations

Qi, Yangyang, et al.. (2023). Research on Traffic Congestion Forecast Based on Deep Learning. Information. 14(2). 108–108. 12 indexed citations

Zheng, Li, Yangyang Qi, Sijie Wang, et al.. (2023). Cost-of-illness of gastroenteritis caused by rotavirus in Chinese children less than 5 years. Human Vaccines & Immunotherapeutics. 19(3). 2276619–2276619. 3 indexed citations

Wang, Xuanyi, Syed Faisal Mahmood, Wee Kooi Cheah, et al.. (2022). Efficacy of Heterologous Boosting Using Recombinant SARS-CoV-2 Fusion Protein Vaccine: A Randomized, Double-Blind and Placebo-Controlled Phase III Trial. SSRN Electronic Journal. 1 indexed citations

Qi, Yangyang & Jiong Wu. (2022). Performance feedback, succession process and innovative activities of family firms: evidence from China. Asian Business & Management. 22(2). 765–791. 2 indexed citations

Wang, Xuanyi, Syed Faisal Mahmood, Wee Kooi Cheah, et al.. (2022). Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial. Emerging Microbes & Infections. 11(1). 1910–1919. 28 indexed citations

Wang, Yongji, Yangyang Qi, Yuansheng Hu, et al.. (2020). Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction. Human Vaccines & Immunotherapeutics. 16(10). 2559–2564. 5 indexed citations

Qi, Yangyang, Wei Wei, & Rui Han. (2020). Research on Regional Multi-Airport Passenger Source Competition Based on Hotelling Model. 237–245.

10.

Li, Ruochen, Hao Liu, Jieti Wang, et al.. (2020). Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis. British Journal of Cancer. 122(10). 1525–1534. 36 indexed citations

11.

Li, Ruochen, Heng Zhang, Yifan Cao, et al.. (2020). Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer. Cancer Immunology Immunotherapy. 69(7). 1327–1336. 23 indexed citations

12.

Hu, Baoying, Zewei Wang, Han Zeng, et al.. (2020). Blockade of DC-SIGN+ Tumor-Associated Macrophages Reactivates Antitumor Immunity and Improves Immunotherapy in Muscle-Invasive Bladder Cancer. Cancer Research. 80(8). 1707–1719. 67 indexed citations

13.

Zhou, Quan, Yangyang Qi, Zewei Wang, et al.. (2020). CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 8(1). e000228–e000228. 24 indexed citations

14.

Qi, Yangyang, Yuan Chang, Zewei Wang, et al.. (2019). Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response. Cancer Immunology Immunotherapy. 68(12). 2067–2080. 36 indexed citations

15.

Wang, Xiaolong, et al.. (2019). Alteration of scaffold: Possible role of MACF1 in Alzheimer’s disease pathogenesis. Medical Hypotheses. 130. 109259–109259. 7 indexed citations

16.

Lin, Chao, Hongyong He, Hao Liu, et al.. (2019). Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut. 68(10). 1764–1773. 283 indexed citations

17.

Xiong, Ying, Li Liu, Yu Xia, et al.. (2019). Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma. Cancer Immunology Immunotherapy. 68(5). 731–741. 40 indexed citations

18.

Fu, Qiang, Le Xu, Yiwei Wang, et al.. (2018). Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion. European Urology. 75(5). 752–763. 164 indexed citations

19.

Cheng, Xinwen, et al.. (2018). Evaluation of the Ability of Spectral Indices of Hydrocarbons and Seawater for Identifying Oil Slicks Utilizing Hyperspectral Images. Remote Sensing. 10(3). 421–421. 20 indexed citations

20.

Song, Yufei, Yangyang Qi, Chanjuan Li, et al.. (2016). Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study. Human Vaccines & Immunotherapeutics. 12(10). 2595–2602. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact